STUDY QUESTION: Does single cleavage-stage (Day 3) embryo transfer using a time-lapse (TL) hierarchical classification model achieve comparable ongoing pregnancy rates (OPR) to single blastocyst (Day 5) transfer by conventional morphological (CM) selection?
Introduction
Transferring multiple embryos increases the possibility of pregnancy in the IVF practice. However, this may bring multiple pregnancies and a higher risk of complications for women and their newborn babies (McLernon et al., 2010) . Elective single embryo transfer (eSET) is proposed as the best practice for a term singleton live birth in ART (Practice Committee of Society for Assisted Reproductive Technology et al., 2012) .
Single blastocyst culture and transfer is a clinically adopted eSET which has a clinical pregnancy rate of 50-60% (Gardner et al., 2004; Sadasivam and Sadasivam, 2008) per transfer. However, extended embryo culture to the blastocyst stage may increase epigenetic alterations (Niemitz and Feinberg, 2004; White et al., 2015) . Studies have also shown blastocyst-stage transfer may result in a higher likelihood of monozygotic twins (Luke et al., 2014; Sotiroska et al., 2015) , a skewed sex ratio (Maheshwari et al., 2016) and preterm delivery (Dar et al., 2014) . SET at the cleavage stage can be an alternative. However, previous studies have shown that clinical pregnancy rates associated with SET at the cleavage stage are significantly lower compared with SET at the blastocyst stage (Papanikolaou et al., 2006; Glujovsky et al., 2016) , which might be possibly attributable to the use of morphological criteria on Day 3. Therefore, optimizing a reliable method to select the cleavage-stage embryos with developmental competence is needed.
Time-lapse systems (TLS) have increasingly been introduced to fertility laboratories for better identification of quality embryos to give more confidence in eSET (Herrero and Meseguer, 2013) . Although an increasing number of studies have presented models and algorithms for embryo selection through TLS in the IVF laboratory, evidence supporting their utility is insufficient (Kahraman et al., 2012; Armstrong et al., 2015; Goodman et al., 2016; Rubio et al., 2014) . Studies have been limited by an inability to adjust the confounding by culture system, embryo transfer (ET) method, and oocyte origin. We designed a randomized controlled study aimed at comparing the ongoing pregnancy rate (OPR) from single cleavage-stage ET using our hierarchical classification model (Yang et al., 2015) (D3 + TL) to single blastocyst transfer using conventional morphological (CM) selection (D5 + CM).
Materials and Methods

Study design and participants
This study was a single-centre, randomized, open-label, active comparatorcontrolled clinical trial assessing the non-inferiority of D3 + TL against D5 + CM for women scheduled IVF (ChiCTR-ICR-15006600). The study design did not include a study arm of Day 3 SET with morphology, as there was concern that such a study design may impede patient recruitment due to the prevalence of Day 3 double ET with morphological selection in routine IVF practice in China. The study was conducted between October 2015 and April 2017 at a tertiary IVF centre (the Reproductive and Genetic Hospital of CITIC-Xiangya, China). The trial sponsor has no role in the design, analysis and report of the study. The study was conducted in accordance with the guidelines of the International Conference on Harmonization, and was approved by the Independent Ethics Committee of the hospital. Written informed consent was obtained from all patients before study screening commenced.
Patients were qualified for inclusion if they were Chinese females aged ≤36 years and undergoing their first or second fresh IVF procedure (IVF or ICSI) using their own oocytes, had FSH levels ≤12 IU/mL on Day 3 of the cycle, more than 10 oocytes retrieved, and were willing to have SET. Patients were excluded if they had underlying uterine conditions including endometriosis, untreated unilateral or bilateral hydrosalpinx, and uterine myoma (multiple, submucous or intramural myoma >3 cm), or had cycles planned for oocyte donation or PGD, or had recurrent pregnancy loss. Also excluded were patients who had significantly abnormal oocytes, or <6 normally fertilized embryos (2PN) or who were considered unlikely to complete the study based on the investigator's judgement.
Randomization and procedures
Patients were randomized in a 1:1 ratio to D3 + TL or D5 + CM via online-generated blocks (www.random.org) once they had 2PN (≥6 normally fertilized oocytes) on Day 1 of the cycle. The study investigators (Y.L.L. and X.Y.K.) created the randomization list and study nurses who were unaware of the study protocol enveloped the randomized allocation in a consecutive order. The investigator (Y.L.L.) assessed the patient's eligibility and performed the randomization by opening the sealed envelopes. The subject was excluded from the study post-randomization if she did not undergo fresh transfer due to any unforeseen reason including ovarian hyper-stimulation or uterine disorders. The study was not operationally feasible to blinding and the investigator and the subject were both aware of the study interventions that they were following.
Ovarian stimulation and insemination
Ovarian stimulation protocols were carried out according to the subject's ovarian reserve (Cheng et al., 2012) . Oocytes were collected 34-36 h after hCG administration by transvaginal ultrasound. All the oocytes were placed in fertilization medium (G-IVF; Vitrolife, Goteborg, Sweden) at 6% CO 2 in the air and at 37°C for 4 h before fertilization using the standardized insemination protocols by conventional IVF or ICSI, or a combination of both (split IVF-ICSI).
Embryo culture and time-lapse recording
Fertilization was assessed 16-18 h after insemination. All normally fertilized zygotes (2PN) were placed individually into the microwells of a specially designed well-of-the-well culture dish (Vitrolife; Budapest, Hungary) and cultured in sequential media (G1.5, Vitrolife; Goteborg, Sweden). All the embryos were placed in a 37°C incubator with 6% CO 2 , 5% O 2 and 89% N 2 and cultured to the cleavage stage (Day 3) in a Primo Vision time-lapse system (Vitrolife). In the control group, the culture medium was changed in the afternoon on Day 3 and all the embryos were then individually transferred to sequential media (G2.5, Vitrolife) and cultured to the blastocyst stage (Day 5) at 37°C in 6% CO 2 , 5% O 2 and 89% N 2 in a COOK mini-incubator.
Embryo scoring and selection
In the study group (D3 + TL), embryo scoring and selection was performed by analysis of time-lapse images of each embryo using computer-equipped software (Primo Vision Analyzer, Vitrolife). Images of each embryo were acquired every 5 min. Embryo selection for transfer on Day 3 was done by a previously developed hierarchical classification model in the centre (Yang et al., 2015) . In the model, abnormal embryo cleavages were classified into two division behaviour categories based on their impact on blastocyst formation [CI: distorted cytoplasmic movement, uneven blastomeres or big fragment events (low impact); CII: developmental arrest, direct cleavage, disordered division or fragmentation event (significant impact)]. An algorithm to predict developmental potential of Day 3 embryos to blastocyst formation (and quality blastocyst) by three step-wise (hierarch) cleavages was then created. Embryo cleavage at each step was categorized as normal cleavage (NC), CI or CII and an associated probability of blastocyst formation was given and classified as A-F by descending order. After fresh SET on Day 3, supernumerary embryos were cryopreserved ( Supplementary  Fig. S1 ).
In the control group (D5 + CM), blastocysts were scored according to Gardner's scoring system (Gardner and Schoolcraft, 1999) and assessed and selected morphologically on Day 5 by the site's embryologist who had not been involved in Day 3 time-lapse imaging and selection.
Outcome measures and endpoints
Transvaginal ultrasound examination was performed 4-12 weeks after ET to detect the presence of gestational sacs and foetal heartbeat. In addition, surgical visualization and histopathology were performed whenever necessary to assess ectopic pregnancy. Sex hormone levels including FSH and hCG were monitored based on routine IVF practice. Figure 1 Study flow diagram. Subjects may have been excluded from the PP analysis for more than one reason, but were counted in only one outstanding exclusion category. Subjects were excluded from the PP analysis due to major protocol deviations including consent withdrawal and violations of study procedures leading to missing clinical/laboratory assessment on OPR or failure to transfer by the assigned intervention; *1 subject had abnormal zona pellucida precluding D3 + TL intervention;^7 subjects withdrew consent and had D3 DET; & 11 and 14 subjects withdrew consent and had D3 or D5 DET, respectively; 2PN: normally fertilized zygotes; OHSS: ovarian hyper-stimulation syndrome; ICSI: intracytoplasmic sperm injection; D3 + TL: Day 3 Time-Lapse single embryo selection; D5 + CM: Day 5 conventional morphology single embryo selection; mITT: modified-Intentionto-treat; PP: per protocol; SET: single embryo transfer; DET: double embryo transfer.
The primary endpoint of this study was OPR, with ongoing pregnancy defined as the presence of a gestational sac with foetal heartbeat by transvaginal ultrasound at week 12 after ET. Secondary endpoints were the rates of implantation (defined as the presence of a gestational sac by transvaginal ultrasound at week 4 after ET), twin pregnancy (monozygotic twins), ectopic pregnancy (a pregnancy outside the uterine detected by ultrasound plus surgical visualization or histopathology) and early miscarriage (defined as the spontaneous loss of an intra-uterine pregnancy ≤12 weeks of gestational age).
Statistical analysis
Sample size calculation A sample size of 600 subjects with~520 in the per protocol (PP) analysis would yield 80% power to demonstrate non-inferiority of D3 + TL to D5 + CM on OPR, assuming a one-sided 2.5% significance level and an OPR of 70% in the D5 + CM group. The OPR in the control group was estimated based on the review of recent unpublished experience from the site. The choice of non-inferiority margin by −10% was considered to assure that the D3 + TL group preserves 85% of the clinical effect from the D5 + CM group on OPR (FDA, 2016; Groenewoud et al., 2016; Gupta et al., 2016) . The D5 + CM group ended up with an OPR of 64 and 68%, respectively, in the mITT and the PP and the statistical power to establish non-inferiority was lowered to~73%.
Analysed population and endpoints
The intention-to-treat (ITT) population included all subjects who were randomized to the study intervention. The mITT population included all patients who received the allocated intervention (Fig. 1) . The PP population included all patients who had the allocated intervention and completed study procedures as the protocol pre-specified. The primary endpoint was analysed as ITT, mITT and PP, respectively. Secondary endpoints were analysed as mITT and PP.
OPR as point estimate and difference between two groups was calculated, and corresponding two-sided 95% CI were given by using the method of Miettinen and Nurminen. Non-inferiority can be declared if the lower bound of the 95% CI for the difference (D3 + TL -D5 + CM) does not exceed −10%. Superiority can then be concluded without additional hypothesis testing if the 95% CI lies above zero. A missing clinical assessment on OPR was deemed negative in the mITT. For secondary endpoints, inference testing was performed to compare between the two groups and corresponding 95% CI for difference were also given. Univariate and multivariate logistic regression analyses with forward selection were applied to identify the association between the patient's characteristics and OPR in the PP population. 
Results
Subject disposition and characteristics
A total of 868 women underwent study screening, among which 600 subjects were randomized to the study intervention. Of these, 585 subjects (D3 + TL = 290, D5 + CM = 295) were included in the mITT population and 517 (D3 + TL = 261, D5 + CM = 256) were included in the PP population (Fig. 1) . The most frequent reason for the exclusion from the PP population was transfer cancelled by the investigator (n = 12) in the D3 + TL group and consent withdrawn by the subjects (n = 25) in the D5 + CM group, respectively. Table I shows the patient's demographic and clinical characteristics. Overall baseline characteristics and cycle outcomes did not differ significantly between the two groups in the PP population. A majority of subjects had primary infertility (64.6%), underwent IVF (72.3%), and had a grade 8C-I embryo (65.8%). Table II displays the results of OPR in different analysis populations. In the PP population, 59.4% of patients (155/261) in the D3 + TL group and 68.4% of patients (175/256) in the D5 + CM group had an ongoing pregnancy at 12 weeks after ET (Difference: −9.0%, 95% CI: −17.1%, −0.7%, P = 0.03). The D3 + TL resulted in a significantly lower OPR as compared with the D5 + CM group. Similar results were shown in the ITT, i.e. all randomized patients (Difference: −8.3%, 95% CI: −16.1%, −0.5%, P = 0.04). Results of the mITT analysis revealed a marginally significant difference in the OPR between the D3 + TL (56.6%, 164/290) and D5 + CM (64.1%, 189/295) groups (Difference: −7.5%, 95% CI: −15.4%, 0.4%, P = 0.06).
Clinical outcomes
Analyses of secondary endpoints are summarized in Table III. In the PP population, the implantation rate was significantly lower in the D3 + TL group than in the D5 + CM group (64.4 versus 77.0%, P = 0.01). There was no statistical difference in the early miscarriage rate between the two groups. Results were similar in the mITT analysis. Only one ectopic pregnancy occurred in the study and it was in the D3 + TL group.
Logistic regression analysis
The association between the subject's clinical characteristics and OPR was analysed by using univariate and multivariate analysis (Table IV) . Being overweight (BMI > 25 kg/m 2 ) having >10 2PN embryos, and using the study intervention assigned were statistically associated with OPR (all P values <0.10) in single logistic regression and entered into the multivariate analysis. After adjustment in multivariate logistic model, subjects who were overweight (BMI>25 kg/m Data are presented as counts (%) and 95% CI; OPR in all analysed populations was counted as observed event in the group for which study intervention was randomly assigned. All subjects who were randomized but not treated were counted as a non-OPR event in all randomized analysis population.^3 Subjects who had a switch-over to D5 + CM SET in the study group were included in D3 + TL for analysis. Estimated difference: D3 + TL − D5 + CM; relative risk: D3 + TL/D5 + CM; D3 + TL: Day 3 time-lapse SET; D5 + CM: Day 5 conventional morphology SET; mITT: modified-intention-to-treat; PP: per protocol; SET: single embryo transfer.
Subjects who had >10 2PN embryos>10 were significantly more likely to have an ongoing pregnancy (OR: 1.56, 95% CI: 1.08, 2.24, P = 0.02). Subjects who received D5 + CM SET had a 1.52-fold likelihood of ongoing pregnancy (OR: 1.52, 95% CI: 1.05, 2.19, P = 0.03).
Discussion
Our study findings showed that cleavage-stage SET (Day 3) with hierarchical classification time-lapse selection resulted in a significantly lower OPR as compared with blastocyst SET (Day 5) by CM selection in women who had IVF, based on pre-specified hypothesis testing on noninferiority by a margin of −10%. The cleavage-stage SET with time-lapse selection also produced a markedly lower implantation rate.
This study served as the first large randomized controlled trial to compare OPR between D3 + TL and D5 + CM SETs among few published studies. SET was performed and thus the implantation data following ET can be accurately analysed. The incubator system (TLM) for culturing embryos was the same for both study groups during the cleavage stage. Patients followed randomized study procedures in a single large centre which reduced heterogeneity for patient selection. Data on OPR by embryo grades may help to further strengthen the hierarchical classification model.
The study has several limitations. First, a controlled group of Day 3 CM selection was not designed, which precluded a direct comparison between time-lapse system and traditional morphology. Blinding was too complex to execute due to the nature of the study. Bias in outcome assessment occurred as the subject's participation in the study ORs for continuous variables represent the increased odds of ongoing pregnancy based on 1 SD increase in the risk factor.^P < 0.10 indicates significant association. The adjusted ORs, 95% CIs and P values in multivariate analysis were estimated from a multiple logistic regression model using forward elimination.
group may be affected by the open-label design. OPR was not as high as pre-specified in the D5 + CM group but was not analysed until patient recruitment ended. Hypothesis testing on non-inferiority was therefore statistically underpowered due to an insufficient sample size caused by lower OPR in the control group. All of the embryos were moved to another incubator after Day 3 so that the control group cultured by two different conditions, which may have an impact on the quality of embryos, affect OPR. Finally, the subject eligibility criteria favoured women with good prognosis. Thus the study results may not be generalizable to a wider patient population in the clinical practice. Several studies have created algorithms by adding a TLS to morphokinetic selection for the aid of ET (Wong et al., 2010; Meseguer et al., 2011) . It has been argued that time-lapse imaging based ET needs more clinical investigations (Armstrong et al., 2015; Kaser et al., 2017) , although blastocyst transfer decreases the number of usable embryos (Glujovsky et al., 2016) and associates with safety concerns including very preterm birth (<32 weeks) and perinatal mortality (Maheshwari et al., 2013; Dar et al., 2014; Maheshwari et al., 2016) . Observational studies have found that TLS combinations are associated with higher implantation rates (Lemmen et al., 2008; Meseguer et al., 2011) and clinical pregnancy rates (Meseguer et al., 2011; Sandrine et al., 2013) . Two RCTs showed an increase in clinical pregnancy rate by using a TL algorithm plus morphokinetic selection (Rubio et al., 2014; Goodman et al., 2016) . Our study, however, has challenged Day 5 SET with CM selection by Day 3 SET with centre-developed time-lapse technology. The OPR was 59.4% in women who were treated as PP in the D3 + TL group, which was comparable to previous RCTs and was higher than that reported in a recent pilot RCT (Kaser et al., 2017) studying an adjuvant time-lapse system to Days 3 and 5 selection versus Day 5 CM (OPR: D3 + TL 38.8%). In the D5 + CM group, the OPR was 68.4% in women who were treated as PP. Our findings did not support non-inferiority of D3 + TL to D5 + CM for OPR. Inversely, the D5 + CM group had a significantly higher OPR than the D3 + TL group. The D5 + CM group also had significantly higher implantation rate. As noted, embryos in the D5 + CM group were incubated in two different culture conditions, which may affect embryo quality for implantation and OPR. But this procedure seemed not to have an impact based on the study's primary results.
There may be some clinical relevance to the significant difference between the two SET strategies. Transferring embryos at the blastocyst stage might timely provide better physiological synchronization between the embryo stage and the endometrium and extended culture may enable embryo self-selection of viable embryos due to embryonic genome activation (Braude et al., 1988; Magli et al., 2000) . Additionally, it was assumed that the uterine environment might welcome blastocyst transfer which allows more recovery time from exposure to super-physiological levels of oestrogen. The observed higher implantation rates may be attributable to this assumption (Elgindy et al., 2011) . In terms of clinically important outcomes, rates of cumulative delivery and live birth were not included as analysed endpoints at the time of study design. This relevant study data needs follow-up observation, which merits further investigations.
Conclusion
Single cleavage-stage ET using time-lapse selection resulted in a significantly lower OPR than single blastocyst transfer with CM selection.
Single cleavage-stage embryo transfer produced a clinically acceptable OPR but remains investigational for IVF practice.
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